NCT01350895

Brief Summary

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
781

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 10, 2011

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

November 6, 2013

Status Verified

November 1, 2013

Enrollment Period

1.2 years

First QC Date

May 9, 2011

Last Update Submit

November 4, 2013

Conditions

Polycystic Ovary Syndrome

Keywords

Polycystic ovarian syndrome (PCOS)

Study Arms (2)

Experimental Group

Control Group

Eligibility Criteria

Age18 Years - 46 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Reproductive age women

You may qualify if:

  • Reproductive age women with sufficient data

You may not qualify if:

  • Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome)
  • women who had had menarche at less than 3 years of age, Day 3 FSH \> 15, or who were older than 46
  • women with inadequate clinical/biochemical records
  • and women who had had ovarian cysts or ovarian tumors in ultrasonography examination
  • pregnancy women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University-WanFang Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Ming-I Hsu

    Taipei Medical University WanFang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Doctor

Study Record Dates

First Submitted

May 9, 2011

First Posted

May 10, 2011

Study Start

February 1, 2011

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

November 6, 2013

Record last verified: 2013-11

Locations

TW(1)